International Journal of Rheumatology
Q2IF2.3SJR0.457
US
USJournal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | — | — | 0.457 | Q3 | 57.7% | |
| 2024 | — | — | 0.572 | Q3 | 66.8% | |
| 2023 | 2.3 | Q2 | 52.6% | 0.644 | Q3 | 73.0% |
| 2022 | 2.3 | 49.1% | 0.365 | Q3 | 56.5% | |
| 2021 | — | 34.6% | 0.366 | Q3 | 57.6% | |
| 2020 | — | — | 0.800 | Q3 | 79.7% | |
| 2019 | — | — | 0.663 | Q2 | 75.5% | |
| 2018 | — | — | 0.545 | Q3 | 67.9% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
eISSN
1687-9279
ISSN
1687-9260
country
UScoverage
2010-2024